Insomnia disorder

A 77-year-old overweight woman with hypertension and arthritis reports that she has had trouble sleeping for “as long as I can remember.” She has taken hypnotic medications nightly for almost 50 years; her medication was recently switched from lorazepam (1 mg), which had been successful, to trazodone (25 mg) by her primary care physician, who was concerned about her use of the former. She spends 9 hours in bed, from 11 p.m. to 8 a.m. She has only occasional difficulty falling asleep, but she awakens two to three times per night to urinate and lies in bed for over an hour at those times, “just worrying.” How should her case be managed?

[1]  Lee M Ritterband,et al.  Efficacy of an Internet-based behavioral intervention for adults with insomnia. , 2009, Archives of general psychiatry.

[2]  M. Sateia,et al.  Clinical guideline for the evaluation and management of chronic insomnia in adults. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[3]  Ronald C Kessler,et al.  The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. , 2012, Archives of general psychiatry.

[4]  C. Lines,et al.  Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial , 2014, The Lancet Neurology.

[5]  Adam D Bramoweth,et al.  Deployment-Related Insomnia in Military Personnel and Veterans , 2013, Current Psychiatry Reports.

[6]  A. Pariente,et al.  Benzodiazepine use and risk of Alzheimer’s disease: case-control study , 2014, BMJ : British Medical Journal.

[7]  D. Dijk,et al.  British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders , 2010, Journal of psychopharmacology.

[8]  C. Morin,et al.  Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. , 2005, Sleep.

[9]  A. Krystal,et al.  Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. , 2007, Sleep.

[10]  Ronald C Kessler,et al.  Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). , 2011, Sleep.

[11]  Duanping Liao,et al.  Insomnia With Objective Short Sleep Duration and Incident Hypertension: The Penn State Cohort , 2012, Hypertension.

[12]  I. Janszky,et al.  Insomnia and the Risk of Acute Myocardial Infarction: A Population Study , 2011, Circulation.

[13]  Duanping Liao,et al.  Insomnia With Objective Short Sleep Duration Is Associated With Type 2 Diabetes , 2009, Diabetes Care.

[14]  J. Dartigues,et al.  Benzodiazepine use and risk of dementia: prospective population based study , 2012, BMJ : British Medical Journal.

[15]  T. Roth,et al.  Treatment regimen and hypnotic self-administration , 2001, Psychopharmacology.

[16]  C. Morin,et al.  The natural history of insomnia: a population-based 3-year longitudinal study. , 2009, Archives of internal medicine.

[17]  K. Stechuchak,et al.  Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. , 2009, Sleep.

[18]  M. Bloch,et al.  Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders , 2013, PloS one.

[19]  B. Kolla,et al.  Pharmacological treatment of insomnia in alcohol recovery: a systematic review. , 2011, Alcohol and alcoholism.

[20]  C. Morin,et al.  Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. , 2005, Behaviour research and therapy.

[21]  Karim M Khan,et al.  Meta-analysis of the impact of 9 medication classes on falls in elderly persons. , 2009, Archives of internal medicine.

[22]  Ronald C. Kessler,et al.  Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the A , 2011, Biological Psychiatry.

[23]  Kathryn A. Lee,et al.  Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. , 2004, Clinical therapeutics.

[24]  R. I. Reeves Comparison of Triazolam, Flurazepam, and Placebo as Hypnotics in Geriatric Patients with Insomnia , 1977, Journal of clinical pharmacology.

[25]  E. Camargos,et al.  Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[26]  F. Hu,et al.  Association Between Insomnia Symptoms and Mortality: A Prospective Study of US Men , 2014, Circulation.

[27]  Hans Ivers,et al.  Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. , 2009, JAMA.

[28]  C. Morin,et al.  Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem , 2017, Sleep.

[29]  J. Winkelman,et al.  National use of prescription medications for insomnia: NHANES 1999-2010. , 2014, Sleep.

[30]  P. Becker,et al.  Novel therapeutic usage of low-dose doxepin hydrochloride , 2007, Expert opinion on investigational drugs.

[31]  C. Alessi,et al.  Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. , 2006, Sleep.

[32]  T. Joiner,et al.  Sleep problems outperform depression and hopelessness as cross-sectional and longitudinal predictors of suicidal ideation and behavior in young adults in the military. , 2012, Journal of affective disorders.

[33]  D. Ford,et al.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.

[34]  Maurice M Ohayon,et al.  Epidemiology of insomnia: what we know and what we still need to learn. , 2002, Sleep medicine reviews.

[35]  M. Partinen,et al.  Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. , 2009, Sleep.

[36]  S. Quello,et al.  Gabapentin treatment for alcohol dependence: a randomized clinical trial. , 2014, JAMA internal medicine.

[37]  S. Kyle,et al.  Insomnia and health-related quality of life. , 2010, Sleep medicine reviews.

[38]  Sati Mazumdar,et al.  Efficacy of brief behavioral treatment for chronic insomnia in older adults. , 2011, Archives of internal medicine.

[39]  C. Campanelli American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .

[40]  D. Kansagara,et al.  Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. , 2016, Annals of internal medicine.

[41]  L. Epstein,et al.  Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning. , 2014, Sleep.

[42]  K. Brower,et al.  Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients , 2003, Psychiatry and clinical neurosciences.

[43]  J. Avorn,et al.  Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. , 2001, The American journal of psychiatry.

[44]  A. Egberts,et al.  The Relationship between Benzodiazepine Use and Traffic Accidents , 2010, CNS drugs.

[45]  Ellyn E Matthews,et al.  Adherence to cognitive behavioral therapy for insomnia: a systematic review. , 2013, Sleep medicine reviews.

[46]  A. Harvey,et al.  (Mis)perception of sleep in insomnia: a puzzle and a resolution. , 2012, Psychological bulletin.

[47]  C. Lines,et al.  Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials , 2016, Biological Psychiatry.

[48]  Kai Spiegelhalder,et al.  Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. , 2011, Journal of affective disorders.

[49]  Randon S. Welton,et al.  Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis , 2015, Journal of psychiatric practice.

[50]  A. Krystal,et al.  Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. , 2011, Sleep.

[51]  P. Gehrman,et al.  Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review , 2012, BMC Family Practice.

[52]  M. Fava,et al.  Residual symptoms in depressed patients who respond acutely to fluoxetine. , 1999, The Journal of clinical psychiatry.

[53]  W. Rief,et al.  Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials , 2014, CNS Drugs.

[54]  C. Dufouil,et al.  Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging Study , 2002, Journal of clinical psychopharmacology.

[55]  J. Edinger,et al.  Sensitivity and specificity of polysomnographic criteria for defining insomnia. , 2013, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[56]  I. Janszky,et al.  Insomnia and the risk of incident heart failure: a population study. , 2014, European heart journal.

[57]  A Niroshan Siriwardena,et al.  Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. , 2014, Sleep.

[58]  A. Krystal,et al.  Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. , 2011, Archives of general psychiatry.

[59]  J. Coyne,et al.  Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study , 2007, Journal of General Internal Medicine.

[60]  B. Sproule,et al.  Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits , 2005, BMJ : British Medical Journal.

[61]  I. Janszky,et al.  Insomnia symptoms and risk for unintentional fatal injuries--the HUNT Study. , 2014, Sleep.

[62]  M. Ohayon,et al.  Place of chronic insomnia in the course of depressive and anxiety disorders. , 2003, Journal of psychiatric research.

[63]  Duanping Liao,et al.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. , 2013, Sleep medicine reviews.

[64]  C. Morin,et al.  Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. , 2004, The American journal of psychiatry.

[65]  A. Krystal,et al.  Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. , 2008, Sleep.

[66]  T. Roth,et al.  Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. , 2007, Sleep.

[67]  M. Bonnet,et al.  Hyperarousal and insomnia: state of the science. , 2010, Sleep medicine reviews.

[68]  C. Morin,et al.  Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[69]  B. Sproule,et al.  Effects of 2-Week Treatment With Temazepam and Diphenhydramine in Elderly Insomniacs: A Randomized, Placebo-Controlled Trial , 2008, Journal of clinical psychopharmacology.

[70]  A. Krystal,et al.  Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. , 2010, Sleep.